All posts in New Business Development

Rubicon is ten years old and is as busy as ever.  In recent months we have:

  • Continued to work in the Dorset system helping Dorset Healthcare NHSFT with its HIP2 capital investment business cases.
  • Won new work with Dorset County Hospital also linked to HIP2 funding.
  • Commenced work with colleagues from other SMEs to develop a health and care hub in Ely.
  • Completed the outline business case for two new mental health units in Surrey and subsequently worked with our client to bid for central funds for the first scheme.
  • Won a new piece of work helping Worcestershire Health & Care to develop their estate strategy – almost ten years since the first time we worked with this trust.
  • Continued to review ETTF bids for NHSE.
  • Completed our work with the Adult Cerebral Palsy Hub.
  • Started a project for overseas investors looking at opportunities in England.
  • Continued to support colleagues in SCWCSU by placing interim staff.


Today marks Rubicon’s tenth anniversary. Over the last ten years the company has delivered over 200 projects for more than 50 clients predominantly in the NHS, but also private health providers and charities. The company works through an associate network and partnerships with other SMEs; currently we have an associate network of 53 compared to 12 when Rubicon was launched. Rubicon continues to be busy and is currently engaged as lead or a sub-contractor, on nine projects for clients ranging from NHSE, a charity and four NHS providers.

Shareholder presentation

Categories: Market Assessments, New Business Development
Comments Off on Shareholder presentation

Rubicon attended the annual general meeting of Milestones Hospital in Norwich last week to present our market assessment report to shareholders. Our report outlined a number of opportunities for the independent sector provider to pursue in the mental health inpatient market.

CSU business planning

Categories: Market Assessments, New Business Development, Strategic Planning
Comments Off on CSU business planning

NHS South, Central and West CSU has asked Rubicon to help it develop its business plan for 2016/17. The CSU is one of the largest in England having been created from a merger of three CSUs in April 2015. It now needs a new strategy and business plan to reflect the new entity. Rubicon will be working with CSU colleagues over the period to mid-February to deliver this project.

Oxford University Hospitals NHS Trust’s board has approved the full business case for investing £16.5m in the development of a satellite radiotherapy centre in Swindon. Approval of the business case is the culmination of three years’ work by Rubicon, its partner consultancies (Health Strategies and WT Partnership) and the trust. Swindon and Wiltshire are among the few areas in England where cancer patients have to travel more than 45 minutes for radiotherapy – they are currently treated at the Churchill Hospital in Oxford, which usually involves daily visits for between four and seven weeks. Director of clinical services at OUH, Paul Brennan, described the decision as “another major step in our project to deliver our services to cancer patients in Swindon and Wiltshire, much nearer to their homes”. Dr Guy Rooney, medical director for GWH, said the Swindon unit was now “within touching distance”. building work will start later this year with the unit due to open its doors for patients in August 2017. The full business case can be downloaded here:

Rubicon has been appointed as the strategic partner for the new South, Central and West CSU following a procurement under the Elis Group Framework. Andy Whiting said, “we are delighted to have been appointed as the new CSUs strategic partner and look forward to working in partnership with the CSU”. South, Central and West CSU is a new CSU being formed from the merger of South West, South Central and South CSUs.

Royal Marsden grant

Categories: - Latest news, Business Case Support, New Business Development
Comments Off on Royal Marsden grant

Last autumn Rubicon and Consilium Strategy worked on a business case for the ICR and Royal Marsden for the acquisition of one of the world’s first MR-Linacs.  The MR Linac combines two technologies – an MRI scanner and a linear accelerator – to precisely locate tumours, tailor the shape of X-ray beams in real time, and accurately deliver doses of radiation even to moving tumours.  George Osborne has just announced a grant of £10m towards the acquisition.